The kappa opioid receptor / Lee-Yuan Liu-Chen, Saadet Inan, editors.
2022
RC483.5.O64 K36 2022
Linked e-resources
Linked Resource
Concurrent users
Unlimited
Authorized users
Authorized users
Document Delivery Supplied
Can lend chapters, not whole ebooks
Details
Title
The kappa opioid receptor / Lee-Yuan Liu-Chen, Saadet Inan, editors.
ISBN
9783030890742 (electronic bk.)
3030890740 (electronic bk.)
9783030890735
3030890732
3030890740 (electronic bk.)
9783030890735
3030890732
Published
Cham : Springer, [2022]
Copyright
©2022
Language
English
Description
1 online resource : illustrations (some color)
Item Number
10.1007/978-3-030-89074-2 doi
Call Number
RC483.5.O64 K36 2022
Dewey Decimal Classification
615.7/822
Summary
This book covers the latest knowledge in structure, signaling, and biochemical pharmacology of KOR as well as preclinical research and clinical applications (including clinical phase studies and approved for human use) of KOR compounds. It is divided up into the three parts: Molecular aspects of KOR, Preclinical research on pharmacology of KOR agonists and antagonists in animals and KOR agonists and antagonists in clinical use and in past and present clinical trials. The chapters "Biosensors monitor ligand-selective effects at kappa opioid receptors" and "The role of dynorphin and the kappa opioid receptor in schizophrenia and major depressive disorder: a translational approach" of this book are available open access under a Creative Commons Attribution 4.0 International License via link.springer.com
Access Note
Access limited to authorized users.
Digital File Characteristics
text file
PDF
Source of Description
Online resource; title from PDF title page (SpringerLink, viewed December 2, 2021).
Added Author
Series
Handbook of experimental pharmacology ; v. 271. 1865-0325
Available in Other Form
Print version: 9783030890735
Linked Resources
Record Appears in
Table of Contents
From the contents. Preface.-Part I: Molecular aspects of KOR
Part II: Preclinical research on pharmacology of KOR agonists and antagonists in animals
Part III: KOR agonists and antagonists in clinical use and in past and present clinical trials.
Part II: Preclinical research on pharmacology of KOR agonists and antagonists in animals
Part III: KOR agonists and antagonists in clinical use and in past and present clinical trials.